Cynata Therapeutics snares former AstraZeneca project manager to advance … – Proactive Investors Australia
| Proactive Investors Australia Dr Kelly will be a member of Cynata’s executive management team and will lead the regulatory, pre-clinical and clinical development of the company’s proprietary Cymerus™ stem cell product pipeline. Dr. Kelly most recently served as Senior Director for … |
